Ansa Biotechnologies

Company Overview

Ansa Biotechnologies, founded as a spinout from the University of California, Berkeley, is involved in next-generation enzymatic DNA synthesis. It has developed a unique enzymatic DNA synthesis platform designed to overcome the length, complexity, and accuracy constraints of traditional phosphoramidite-based DNA synthesis. Its method, based on TdT-dNTP conjugates, enables the synthesis of extremely complex sequences with few sequence limitations and regulated single-base DNA extension. Nucleotides are added one at a time in a regulated manner using terminal deoxynucleotidyl transferase (TdT)-dNTP conjugates in Ansa's exclusive enzymatic DNA synthesis platform. The method is fully aqueous and avoids exposure of DNA to harsh reagents, in contrast to conventional phosphoramidite chemistry. This improves sequence integrity and enables the synthesis of challenging motifs.

Company's Business Segments

• DNA Synthesis : The company provides manufactured synthetic DNA that overcomes the limitations of traditional DNA synthesis methods by using enzymatic DNA synthesis technology.